Integrity of the blood–cerebrospinal fluid barrier in early Parkinson's disease
- 16 March 2001
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 300 (3) , 182-184
- https://doi.org/10.1016/s0304-3940(01)01574-9
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Interleukin-1β and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patientsPublished by Elsevier ,2003
- Oligoclonal bands in cerebrospinal fluid:a comparative study of isoelectric focusing, agarose gel electrophoresis and IgG indexActa Neurologica Scandinavica, 2000
- Physiology and pathology of the blood-brain barrier: implications for microbial pathogenesis, drug delivery and neurodegenerative disordersJournal of NeuroVirology, 1999
- Glial cells and inflammation in parkinson's disease: A role in neurodegeneration?Annals of Neurology, 1998
- Decreased cerebrospinal fluid levels of neutral and basic amino acids in patients with Parkinson's diseaseJournal of the Neurological Sciences, 1997
- Blood-Cerebrospinal Fluid Barrier Dysfunction for High Molecular Weight Proteins in Alzheimer Disease and Major DepressionAlzheimer Disease & Associated Disorders, 1997
- Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's diseaseNeuroscience Letters, 1994
- Alcohol consumption and blood-cerebrospinal fluid barrier dysfunction in manNeuroscience Letters, 1987
- “Mini-mental state”Journal of Psychiatric Research, 1975
- ParkinsonismNeurology, 1967